214 related articles for article (PubMed ID: 23432158)
1. The Wnt pathway: emerging anticancer strategies.
Gupta A; Verma A; Mishra AK; Wadhwa G; Sharma SK; Jain CK
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):138-47. PubMed ID: 23432158
[TBL] [Abstract][Full Text] [Related]
2. Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Luu HH; Zhang R; Haydon RC; Rayburn E; Kang Q; Si W; Park JK; Wang H; Peng Y; Jiang W; He TC
Curr Cancer Drug Targets; 2004 Dec; 4(8):653-71. PubMed ID: 15578921
[TBL] [Abstract][Full Text] [Related]
3. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
5. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
7. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
8. Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.
Hankey W; Frankel WL; Groden J
Cancer Metastasis Rev; 2018 Mar; 37(1):159-172. PubMed ID: 29318445
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
10. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
11. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
[TBL] [Abstract][Full Text] [Related]
12. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
13. FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.
Gao C; Chen G; Kuan SF; Zhang DH; Schlaepfer DD; Hu J
Elife; 2015 Sep; 4():. PubMed ID: 26274564
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
15. 1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M.
Kundu A; Khouri MG; Aryana S; Firestone GL
Carcinogenesis; 2017 Dec; 38(12):1207-1217. PubMed ID: 29028954
[TBL] [Abstract][Full Text] [Related]
16. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies.
Yang K; Wang X; Zhang H; Wang Z; Nan G; Li Y; Zhang F; Mohammed MK; Haydon RC; Luu HH; Bi Y; He TC
Lab Invest; 2016 Feb; 96(2):116-36. PubMed ID: 26618721
[TBL] [Abstract][Full Text] [Related]
17. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.
Takahashi-Yanaga F; Sasaguri T
J Pharmacol Sci; 2009 Feb; 109(2):179-83. PubMed ID: 19179804
[TBL] [Abstract][Full Text] [Related]
18. WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line.
Lee H; Bae S; Choi BW; Yoon Y
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):56-65. PubMed ID: 21699440
[TBL] [Abstract][Full Text] [Related]
19. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
[TBL] [Abstract][Full Text] [Related]
20. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]